Cambridge Nutritional Sciences plc provided earnings guidance for the year ended 31 March 2024. for the year, the company expects revenue of £9.8 million (2023: £7.5 million) representing 30% growth.
Cambridge Nutritional Sciences plc
Equities
ODX
GB00B1VCP282
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.55 GBX | -1.39% |
|
-10.13% | +47.92% |
05-24 | Cambridge Nutritional Sciences appoints James Copper as COO | AN |
05-24 | Cambridge Nutritional Sciences Names COO | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+47.92% | 10.9M | |
-10.74% | 11.41B | |
-11.02% | 7.53B | |
+30.85% | 5.62B | |
-16.28% | 3.82B | |
+8.39% | 2.6B | |
-64.67% | 2.37B | |
-10.17% | 2.26B | |
+24.87% | 2.16B | |
-12.06% | 1.71B |
- Stock Market
- Equities
- ODX Stock
- News Cambridge Nutritional Sciences plc
- Cambridge Nutritional Sciences plc Provides Earnings Guidance for the Year Ended 31 March 2024